Genetics and Autoimmunity

Non-MHC Genes

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

This chapter focuses on the contribution of non-major histocompatiblity complex (MHC) genes to the genetic susceptibility to autoimmune diseases. Several non-MHC immune regulatory genes have been shown to be susceptibility genes for autoimmunity. As expected, these genes are not specific for one autoimmune disease but predispose to several autoimmune conditions. However, some variability does exist with certain immune regulatory genes showing a much stronger association with some autoimmune conditions than with others. For example, the (cytotoxic T-lymphocyte antigen-4) CTLA-4 gene shows the strongest association with Graves' disease and a much weaker association with Hashimoto's disease and T1D. Furthermore, whole genome screening is a powerful genetic tool with which to identify loci or genetic regions that might be linked with disease. When a locus, which is linked with disease, is identified, the region can be fine mapped and the gene identified. This strategy has been used successfully in a number of complex diseases, most notably in the mapping and identification of NOD2 as a susceptibility gene for Crohn's disease.

Original languageEnglish (US)
Title of host publicationThe Autoimmune Diseases
PublisherElsevier Inc.
Pages273-287
Number of pages15
ISBN (Print)9780125959612
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Autoimmunity
Genes
Regulator Genes
Autoimmune Diseases
CTLA-4 Antigen
Hashimoto Disease
Genetic Loci
Graves Disease
Genetic Predisposition to Disease
Antigen-Antibody Complex
Crohn Disease
Genome

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Cite this

Tomer, Y. (2006). Genetics and Autoimmunity: Non-MHC Genes. In The Autoimmune Diseases (pp. 273-287). Elsevier Inc.. https://doi.org/10.1016/B978-012595961-2/50024-X

Genetics and Autoimmunity : Non-MHC Genes. / Tomer, Yaron.

The Autoimmune Diseases. Elsevier Inc., 2006. p. 273-287.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tomer, Y 2006, Genetics and Autoimmunity: Non-MHC Genes. in The Autoimmune Diseases. Elsevier Inc., pp. 273-287. https://doi.org/10.1016/B978-012595961-2/50024-X
Tomer, Yaron. / Genetics and Autoimmunity : Non-MHC Genes. The Autoimmune Diseases. Elsevier Inc., 2006. pp. 273-287
@inbook{cd47ab6bf8bd454591af1c744112840d,
title = "Genetics and Autoimmunity: Non-MHC Genes",
abstract = "This chapter focuses on the contribution of non-major histocompatiblity complex (MHC) genes to the genetic susceptibility to autoimmune diseases. Several non-MHC immune regulatory genes have been shown to be susceptibility genes for autoimmunity. As expected, these genes are not specific for one autoimmune disease but predispose to several autoimmune conditions. However, some variability does exist with certain immune regulatory genes showing a much stronger association with some autoimmune conditions than with others. For example, the (cytotoxic T-lymphocyte antigen-4) CTLA-4 gene shows the strongest association with Graves' disease and a much weaker association with Hashimoto's disease and T1D. Furthermore, whole genome screening is a powerful genetic tool with which to identify loci or genetic regions that might be linked with disease. When a locus, which is linked with disease, is identified, the region can be fine mapped and the gene identified. This strategy has been used successfully in a number of complex diseases, most notably in the mapping and identification of NOD2 as a susceptibility gene for Crohn's disease.",
author = "Yaron Tomer",
year = "2006",
doi = "10.1016/B978-012595961-2/50024-X",
language = "English (US)",
isbn = "9780125959612",
pages = "273--287",
booktitle = "The Autoimmune Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Genetics and Autoimmunity

T2 - Non-MHC Genes

AU - Tomer, Yaron

PY - 2006

Y1 - 2006

N2 - This chapter focuses on the contribution of non-major histocompatiblity complex (MHC) genes to the genetic susceptibility to autoimmune diseases. Several non-MHC immune regulatory genes have been shown to be susceptibility genes for autoimmunity. As expected, these genes are not specific for one autoimmune disease but predispose to several autoimmune conditions. However, some variability does exist with certain immune regulatory genes showing a much stronger association with some autoimmune conditions than with others. For example, the (cytotoxic T-lymphocyte antigen-4) CTLA-4 gene shows the strongest association with Graves' disease and a much weaker association with Hashimoto's disease and T1D. Furthermore, whole genome screening is a powerful genetic tool with which to identify loci or genetic regions that might be linked with disease. When a locus, which is linked with disease, is identified, the region can be fine mapped and the gene identified. This strategy has been used successfully in a number of complex diseases, most notably in the mapping and identification of NOD2 as a susceptibility gene for Crohn's disease.

AB - This chapter focuses on the contribution of non-major histocompatiblity complex (MHC) genes to the genetic susceptibility to autoimmune diseases. Several non-MHC immune regulatory genes have been shown to be susceptibility genes for autoimmunity. As expected, these genes are not specific for one autoimmune disease but predispose to several autoimmune conditions. However, some variability does exist with certain immune regulatory genes showing a much stronger association with some autoimmune conditions than with others. For example, the (cytotoxic T-lymphocyte antigen-4) CTLA-4 gene shows the strongest association with Graves' disease and a much weaker association with Hashimoto's disease and T1D. Furthermore, whole genome screening is a powerful genetic tool with which to identify loci or genetic regions that might be linked with disease. When a locus, which is linked with disease, is identified, the region can be fine mapped and the gene identified. This strategy has been used successfully in a number of complex diseases, most notably in the mapping and identification of NOD2 as a susceptibility gene for Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=65249184241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249184241&partnerID=8YFLogxK

U2 - 10.1016/B978-012595961-2/50024-X

DO - 10.1016/B978-012595961-2/50024-X

M3 - Chapter

SN - 9780125959612

SP - 273

EP - 287

BT - The Autoimmune Diseases

PB - Elsevier Inc.

ER -